Background information

In order to enhance research in and the industrial reconversion of the biopharmaceutical sector towards the production of new drugs and vaccines for emerging and widespread infectious diseases, Law Decree No. 41 of 22 March 2021 set up a specific fund with a total budget of €200 million for the year 2021.

Content of measure

The fund set up by Law Decree No. 41 of 22 March 2021, will grant financial concessions in support of private investments in the biopharmaceutical sector aiming at the production of new drugs and vaccines to deal with newly emerging infectious diseases at national level. The fund will support companies in the enhancement of their research investments in the mentioned sector and in their process of industrial reconversion, also through the creation of highly specialised poles, and the implementation of complementary and functional interventions by private companies. The total budget of the initiative amounts to €200 million for the year 2021.

Use of measure

Not yet available.

Target groups

Workers	Businesses	Citizens
Does not apply to workers	Sector specific set of companies	Does not apply to citizens

Actors and funding

Actors	Funding
National government	National funds

Social partners

Social partners' role in designing the measure and form of involvement:

	Trade unions	Employers' organisations
Role	No involvement	No involvement
Form	Not applicable	Not applicable

Social partners' role in the implementation, monitoring and assessment phase:

• No involvement
• Main level of involvement: N/A

Involvement

No involvement in the definition of the measure.

Views and reactions

No information available.

Sectors and occupations

This case is not occupation-specific.

Sources

• 22 March 2021: DECRETO-LEGGE 22 marzo 2021, n. 41 Misure urgenti in materia di sostegno alle imprese e agli operatori economici, di lavoro, salute e servizi territoriali, connesse all'emergenza da COVID-19 (www.gazzettaufficiale.it)